The new generic products which were recently developed. Volunteer will receive a single dose of Venlafaxine Prolonged -release Capsules BP 150 mg of either test or reference with 240 mL of drinking wa
Sponsors
Bio-innova Co., Ltd.
Conditions
Healthy subjects
Bioequivalence Venlafaxine Prolonged-release Capsules BP 150 mg
Phase 1
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Venlafaxine Prolonged -release Capsules BP 150 mg relative to Originator in healthy Thai volunteers under fed condition
TCTR20240426007
Start: 2024-08-13Target: 28Updated: 2026-08-03
A Bioequivalence study of a multiple dose (steady state) randomized, open-label, two-way crossover design with two-period, two-treatment and two-sequence between Venlafaxine Prolonged -release Capsules BP 150 mg in healthy Thai volunteers under fed condition
TCTR20240427014
Start: 2024-10-30Target: 32Updated: 2026-08-03